NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-040-2012-0-IL-68 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen IL DIV 2071-04-29 Issued
NIAID E-191-2023-0-PC-01 METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS PCT PCT PCT/US2022/015835 Expired
NIAID E-135-2010-0-HK-38 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production HK EP 42022047741.8 Pending
NHLBI E-144-2021-0-US-02 Tissue Cutting Systems and Methods US 63/307,939 Expired
NCI E-126-2019-0-US-03 T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY US National Stage 17/633,414 12558424 Issued PDF
NIAID E-037-2021-1-PCT-01 Antibodies Targeting The Spike Protein Of Coronaviruses PCT PCT PCT/US2022/015341 Expired
NCI E-064-2021-0-PCT-03 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection PCT PCT PCT/US2022/015349 Expired
NCI E-029-2019-0-HK-12 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION HK EP 62022047561.5 Pending
NIAID E-037-2021-1-CL-05 Antibodies Targeting The Spike Protein Of Coronaviruses CL National Stage 202302326 Pending
NHGRI E-122-2017-0-US-03 CANCER DETECTION AND CLASSIFICATION US National Stage 17/632,783 Pending
NCI E-040-2012-0-RU-67 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen RU DIV 2022102579 Pending
NIAID E-241-2014-0-JP-09 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof JP DIV 2022-014647 Abandoned
NCATS E-147-2022-0-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/305,834 Expired
NIAID E-042-2018-0-US-08 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US CON 17/590,631 11975063 Issued PDF
NCI E-094-2017-0-JP-01 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-MESOTHELIN IMMUNOTHERAPY JP DIV 2022-014136 Issued
NHLBI E-163-2019-0-US-04 RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS US National Stage 17/631,600 Pending
NIAID E-083-2017-0-US-05 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE US CON 17/587,817 12053520 Issued PDF
NCI E-085-2013-0-JP-31 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR
REACTIVE T CELLS FROM PERIPHERAL BLOOD 		JP DIV 2022-011975 Issued
NCI E-243-2020-0-PCT-02 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER PCT PCT PCT/US2022/014448 Expired
NHLBI E-056-2021-0-PCT-02 A New Molecular Scaffold For Targeting HRpn13 PCT PCT PCT/US2022/014199 Expired
NCATS E-077-2020-2-US-02 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINES AS IRAK 1/4 AND FLT3 INHIBITORS US CON 17/587,070 Abandoned
NHLBI E-056-2021-0-EP-01 A New Molecular Scaffold For Targeting HRpn13 EP National Stage 22704672.9 Pending
NHLBI E-056-2021-0-AU-01 A New Molecular Scaffold For Targeting HRpn13 AU National Stage 2022212029 Abandoned
NHLBI E-056-2021-0-CA-01 A New Molecular Scaffold For Targeting HRpn13 CA National Stage 3209597 Abandoned
NCI E-141-2021-0-US-02 LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 US ORD 17/586,676 12140595 Issued PDF
NIAID E-540-2013-0-US-12 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION US CON 17/649,133 Pending
NCI E-135-2019-0-EP-08 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 EP National Stage 20742583.6 Pending
NCI E-256-2020-0-PCT-04 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		PCT PCT PCT/US2022/013946 Expired
NHLBI E-035-2022-0-US-01 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) US 63/303,190 Expired
NCI E-135-2019-0-KR-15 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 KR National Stage 10-2022-7002872 Pending
NCI E-266-2011-0-IL-60 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 2005-01-29 Issued
NIA E-024-2022-0-US-01 GINGERENONE A PRO-DRUGS AS SENOTHERAPEUTICS AND METHODS OF USE US 63/302,873 Expired
NIAID E-196-2022-0-PCT-02 COMPOUNDS AND METHODS FOR TREATING MALARIA PCT PCT PCT/US2022/013223 Expired
NCI E-135-2019-0-RU-12 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 RU National Stage 2022101295 Issued
NCATS E-262-2016-0-HK-02 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS HK EP 42022046721.1 Abandoned
NCI E-176-2014-0-HK-62 Anti-Human Papillomavirus 16 E7 T Cell Receptors HK CN 42022046605.6 Issued
NCI E-240-2015-1-MO-10 Methods of Analyzing Virus-Derived Therapeutics MO CN J/005746 Issued
NCI E-135-2019-0-IN-09 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 IN National Stage 202247003029 Pending
NHGRI E-104-2019-0-EP-03 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOLXYLASE ALPHA EP National Stage 20743021.6 Pending
NIAID E-045-2015-0-HK-11 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use HK EP 42022046399.6 Abandoned
NCI E-174-2018-2-AU-16 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY AU DIV 2022200267 Abandoned
NCI E-063-2017-0-US-08 DENOISING OF DYNAMIC RESONANCE SPECTROSCOPIC IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN US CON 17/576,283 12270881 Issued PDF
NIAID E-055-2021-0-PCT-02 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use PCT PCT PCT/US2022/012530 Expired
NIAID E-023-2022-1-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 63/299,730 Expired
NCI E-045-2022-0-US-01 METHOD OF HLA LOH DETECTION IN LIQUID BIOPSIES US 63/299,672 Expired
NIDCD E-004-2019-1-HK-08 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY HK EP 62022046132.6 Pending
NIDCD E-004-2019-0-HK-06 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY HK EP 62022046131.8 Pending
NCI E-135-2019-0-ZA-14 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 ZA National Stage 2022/00598 Pending
NCATS E-244-2014-0-US-32 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US CON 17/572,359 11897845 Issued PDF
NCI E-051-2022-0-US-01 PREDICTING PATIENT TREATMENT RESPONSE AND RESISTANCE VIA SINGLE CELL TRANSCRIPTOMICS OF THEIR TUMORS US 63/298,045 Expired